Jean George - 11 Jun 2021 Form 4 Insider Report for Calithera Biosciences, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 11 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2021, 16:05:23 UTC
Next SEC filing: 17 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Jean George

Key filing fact

Jean George filed Form 4 for Calithera Biosciences, Inc. on 14 Jun 2021.

Key facts

This page summarizes Jean George's Form 4 filing for Calithera Biosciences, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2021, 16:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CALA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 11 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $2.28
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/12 of the Option vests in each monthly installment as measured from June 11, 2021, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer. In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction.